ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
16,924.40
-0.35%
다우존스 지수
37,903.29
0.23%
Bitcoin
58,280.48
-3.83%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Exelixis Inc (EXEL)

  7. Exelixis Inc (EXEL) 뉴스

EXEL Exelixis Inc

21.925
-1.54 (-6.54%)
시간외 거래
최종 업데이트: 06:27:13
15분 지연
기업명 주식 심볼 시장 주식 타입
Exelixis Inc EXEL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-1.54 -6.54% 21.925 06:27:13
개장가 저가 고가 종가 전일 종가
21.64 20.69 22.24 21.925 23.46
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:05BWExelixis Announces First Quarter 2024 Financial Results and..
17/04/202405:05BWExelixis to Release First Quarter 2024 Financial Results on..
28/02/202408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:05BWExelixis to Webcast Fireside Chats as Part of Investor..
24/02/202408:33EDGAR2Form 144 - Report of proposed sale of securities
23/02/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202409:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202423:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/02/202406:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/02/202406:28EDGAR2Form 8-K - Current report
07/02/202406:05BWExelixis Announces Fourth Quarter and Fiscal Year 2023..
02/02/202406:05BWExelixis to Webcast Fireside Chats as Part of Investor..
25/01/202422:00BWExelixis Announces Detailed Results of Phase 3 CONTACT-02..
24/01/202406:05BWExelixis to Release Fourth Quarter and Fiscal Year 2023..
23/01/202407:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
19/01/202406:05BWEuropean Patent Office Rules in Favor of Exelixis on..
17/01/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202411:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/01/202411:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/01/202423:06EDGAR2Form 8-K - Current report
08/01/202406:00BWExelixis Announces Preliminary Fiscal Year 2023 Financial..
03/01/202406:05BWExelixis to Present at the 42nd Annual J.P. Morgan..
21/12/202306:20EDGAR2Form 8-K - Current report
15/12/202309:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202309:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202306:56EDGAR2Form 144 - Report of proposed sale of securities
14/12/202306:27EDGAR2Form 144 - Report of proposed sale of securities
13/12/202306:26EDGAR2Form 144 - Report of proposed sale of securities
08/12/202306:05BWExelixis 2023 R&D Day: Science & Strategy to be Webcast on..
05/12/202308:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:02BWExelixis Announces Initiation of the STELLAR-305 Phase 2/3..
04/12/202322:00BWExelixis and Arcus Biosciences Announce Clinical Trial..
01/12/202306:10EDGAR2Form 144 - Report of proposed sale of securities
30/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202306:05BWExelixis to Present at the Piper Sandler 35th Annual..
21/11/202309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202323:00BWExelixis Announces Encouraging Results from Expansion Cohort..
10/11/202306:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
EXEL
Exelixis
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유